Our research project


Melomanes aims to train a new generation of highly skilled doctoral researchers to emerge with a high-level training in the multidisciplinary field of nanomedicine. The goal is to develop a therapy for metastatic melanoma combining magnetic nanoparticles and CAR-T cells.

The strategy is to use the nanoparticles to induce damage on the tumor microenvironment, by magnetic and optic hyperthermia, in order to facilitate the infiltration of CAR-T cells. This therapeutic approach combining hyperthermia and immunotherapy is versatile, as it could be also applied to other types of solid tumors.

A team of experts

An interdisciplinary team is involved in the Melomanes project. It includes supervisors and cosupervisors, doctoral researchers, a European Project Manager, and External Advisory Board Members.

European Commission
European Commission
European Commission

Latest news


Discover our project



Learn more about our research project

Research Outputs

Find out about our research releases and outputs


Get the latest news about the project and the team


Discover a team of international and pluridisciplinary experts


Browse the list of the partners involved in the project

Events & Trainings

Find out about the events and training we propose